MedPath

Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line

Early Phase 1
Conditions
Carcinoma
Tongue Neoplasms
Interventions
Drug: nano-luteolin
Drug: luteolin
Registration Number
NCT03288298
Lead Sponsor
Cairo University
Brief Summary

In vitro study to examine whether luteolin and nano-luteolin exert an inhibitory effect on tongue squamous cell carcinoma cell line by inducing apoptosis, and to assess if nano-luteolin has more efficient apoptotic activity than luteolin on tongue squamous cell carcinoma cell line.

Detailed Description

This study is conducted to examine whether luteolin and nano-luteolin exert an inhibitory effect on tongue squamous cell carcinoma cell line by inducing apoptosis, and to assess if nano-luteolin has more efficient apoptotic activity than luteolin on tongue squamous cell carcinoma cell line. The primary outcome is apoptosis, while the secondary outcome is cell viability.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Squamous cell carcinoma cell lines (OSCC, TSCC and HNSCC).
  • Luteolin 5,7,3',4'-tetrahydroxy-flavone (MeSH term).
  • Application of luteolin as a chemotherapeutic drug.
Read More
Exclusion Criteria
  • Any cancer cell line other than OSCC, TSCC and HNSCC cell lines.
  • Luteolin glycosides.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nano-luteolinnano-luteolinnano-particles derived from a natural extract luteolin
luteolinluteolina natural extract derived flavinoids
Primary Outcome Measures
NameTimeMethod
gene expression of Caspase 3 to detect apoptosis6 hours

fold-changes

Secondary Outcome Measures
NameTimeMethod
cell viability6 hours

micromolar

© Copyright 2025. All Rights Reserved by MedPath